Residency · ATLANTA, GA
Sponsored by Emory University School of Medicine
Phenylketonuria.
Nature reviews. Disease primers · 2021 · 388 citations · Nicola Longo
Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial.
The Lancet. Child & adolescent health · 2024 · 64 citations · William Wilcox
Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study.
Journal of medical genetics · 2024 · 42 citations · William Wilcox, Nicola Longo
Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial.
Lancet (London, England) · 2024 · 41 citations · Nicola Longo
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.
Neurology · 2023 · 66 citations · Nicola Longo
Phenylketonuria and the brain.
Molecular genetics and metabolism · 2023 · 55 citations ·
Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency.
Journal of inherited metabolic disease · 2021 · 92 citations · Nicola Longo
The clinical application of polygenic risk scores: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Genetics in medicine : official journal of the American College of Medical Genetics · 2023 · 74 citations · Mari Mori